For the active immunisation of calves from 12 weeks of age to: • Reduce virus excretion and the clinical signs caused by PI3 virus • Reduce virus excretion caused by BRSV infection, reduce virus excretion and the severity of leucopenia induced by BVDV type 1 infection Onset of immunity: 3 weeks after vaccination. Duration of immunity: 6 months (demonstrated by challenge studies) after vaccination for BRSV and BVDV Type 1. Duration of immunity has not been established for PI3. Efficacy has not been demonstrated against BVDV Type 2 strains. Dosage & Administration 4ml intramuscular Reconstitute the vaccine by mixing the freeze-dried component with the liquid fraction and shake well. Administer the reconstituted vaccine by the intramuscular route.
